Skip to main content
. 2022 Feb 25;9:817957. doi: 10.3389/fmed.2022.817957

Table 2.

Treatment of AEW, Lifukang, and MNZ in GS.

Treating solution Treating time (mins)
5 10 20
Log Survival (CFU/mL) ±standard deviation (SD) Log reduction (CFU/mL) Log survival (CFU/mL) ±standard deviation (SD) Log reduction (CFU/mL) Log survival (CFU/mL) ±standard deviation (SD) Log reduction (CFU/mL)
Control 8.25 ± 0.04a, A 8.52 ± 0.27a, A, B 8.03 ± 0.07a, A, C
10 8.03 ± 0.14a, A 0.22 8.12 ± 0.06b, A, B 0.4 7.60 ± 0.03b, A, C 0.43
20 ND1 8.25 ND 8.52 ND 8.03
30 ND 8.25 ND 8.52 ND 8.03
40 ND 8.25 ND 8.52 ND 8.03
AEW2 (ppm) 50 ND 8.25 ND 8.52 ND 8.03
60 ND 8.25 ND 8.52 ND 8.03
70 ND 8.25 ND 8.52 ND 8.03
80 ND 8.25 ND 8.52 ND 8.03
Lifukang (10%) ND 8.25 ND 8.52 ND 8.03
MNZ3 (0.75%) 6.98 ± 0.15b, A 1.27 6.91 ± 0.09b, A 1.61 6.97 ± 0.11c, A 1.06
1

Not detected.

2

AEW, Acidic electrolyzed water.

3

MNZ, metronidazole.

a−c

Values within the same column with different lowercase letters indicate significantly different (p < 0.05).

A−C

Values within the same row with different uppercase letters indicate significantly different (p < 0.05). Values represent the mean ± standard deviation (n = 3).